Skip to main content

Table 2 Survival rates

From: Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure

 

After Hospital

After 1 year

After 2 years

After 3 years

MARS (n = 33)

n = 22/67%

N = 19/58%

n = 17/52%

n = 17/52%

Controls (n = 46)

n = 29/63%

N = 16/35%

n = 12/26%

n = 8/17%

Total (n = 79)

n = 51/63%

N = 35/44%

n = 29/37%

n = 25/32%

Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us